Terms: = Ovarian cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV
29 results:
1. Amide proton transfer weighted MRI in differential diagnosis of ovarian masses with cystic components: A preliminary study.
Yu Y; Song X; Zeng Z; Wang L; Zhang L; Zhao H; Zheng Z
Magn Reson Imaging; 2023 Nov; 103():216-223. PubMed ID: 37517767
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
3. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
4. Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline ovarian Tumors by Integrative Polygenic Analytics.
Chang CM; Li YF; Lin HC; Lu KH; Lin TW; Liu LC; Su KM; Chang CC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921111
[TBL] [Abstract] [Full Text] [Related]
5. Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
Brum MCM; Dos Santos Guimaraes I; Ferreira LB; Rangel LBA; Maia RC; Nestal De Moraes G; Gimba ERP
Oncol Rep; 2021 Feb; 45(2):652-664. PubMed ID: 33416171
[TBL] [Abstract] [Full Text] [Related]
6. Roads to the strategic targeting of ovarian cancer treatment.
Irusta G
Reproduction; 2021 Jan; 161(1):R1-R11. PubMed ID: 33112290
[TBL] [Abstract] [Full Text] [Related]
7. Novel extra cellular-like matrices to improve human ovarian grafting.
Abir R; Stav D; Taieb Y; Gabbay-Benziv R; Kirshner M; Ben-Haroush A; Freud E; Ash S; Yaniv I; Herman-Edelstein M; Fisch B; Shufaro Y
J Assist Reprod Genet; 2020 Sep; 37(9):2105-2117. PubMed ID: 32710268
[TBL] [Abstract] [Full Text] [Related]
8. pdgfb as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor.
Pazos MC; Sequeira G; Bocchicchio S; May M; Abramovich D; Parborell F; Tesone M; Irusta G
J Cell Physiol; 2018 Aug; 233(8):5949-5961. PubMed ID: 29266203
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma.
Zhang H; Lu J; Lu Y; Zhou J; Wang Z; Liu H; Xu C
PLoS One; 2017; 12(5):e0177520. PubMed ID: 28498842
[TBL] [Abstract] [Full Text] [Related]
10. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
[TBL] [Abstract] [Full Text] [Related]
11. MPV, NLR, and platelet count: new hematologic markers in diagnosis of malignant ovarian tumor.
Yilmaz E; Coskun EI; Sahin N; Ciplak B; Ekici K
Eur J Gynaecol Oncol; 2017; 38(3):346-349. PubMed ID: 29693870
[TBL] [Abstract] [Full Text] [Related]
12. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
[TBL] [Abstract] [Full Text] [Related]
13. Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors.
Inaguma S; Wang Z; Lasota JP; Miettinen MM
Oncotarget; 2016 Aug; 7(34):55276-55289. PubMed ID: 27419370
[TBL] [Abstract] [Full Text] [Related]
14. Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).
Fernández-Guizán A; López-Soto A; Acebes-Huerta A; Huergo-Zapico L; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S
PLoS One; 2015; 10(11):e0140786. PubMed ID: 26536461
[TBL] [Abstract] [Full Text] [Related]
15. Menopausal status strongly influences the utility of predictive models in differential diagnosis of ovarian tumors: an external validation of selected diagnostic tools.
Moszynski R; Zywica P; Wojtowicz A; Szubert S; Sajdak S; Stachowiak A; Dyczkowski K; Wygralak M; Szpurek D
Ginekol Pol; 2014 Dec; 85(12):892-9. PubMed ID: 25669057
[TBL] [Abstract] [Full Text] [Related]
16. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract] [Full Text] [Related]
17. BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.
Tripurani SK; Cook RW; Eldin KW; Pangas SA
Oncogene; 2013 Aug; 32(33):3877-85. PubMed ID: 22964636
[TBL] [Abstract] [Full Text] [Related]
18. Borderline tumors of the ovary: clinical course and prognostic factors.
Ewald-Riegler N; du Bois O; Fisseler-Eckhoff A; Kommoss F; Harter P; Traut A; Hils R; du Bois A
Onkologie; 2012; 35(1-2):28-33. PubMed ID: 22310342
[TBL] [Abstract] [Full Text] [Related]
19. [Roles of vascular endothelial growth factor and platelet-derived growth factor in lymphangiogenesis in epithelial ovarian carcinoma.].
Zhao RW; Yang SH; Cai LQ; Zhang J; Wang J; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):760-4. PubMed ID: 20078963
[TBL] [Abstract] [Full Text] [Related]
20. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Lu C; Shahzad MM; Moreno-Smith M; Lin YG; Jennings NB; Allen JK; Landen CN; Mangala LS; Armaiz-Pena GN; Schmandt R; Nick AM; Stone RL; Jaffe RB; Coleman RL; Sood AK
Cancer Biol Ther; 2010 Feb; 9(3):176-82. PubMed ID: 20009575
[TBL] [Abstract] [Full Text] [Related]
[Next]
